Literature DB >> 10939760

Patterns of sulfadiazine acute nephrotoxicity.

M Crespo1, C Quereda, J Pascual, M Rivera, L Clemente, T Cano.   

Abstract

Sulfadiazine acute nephrotoxicity is reviving specially because of its use in toxoplasmosis in HIV-positive patients. We report 4 cases, one of them in a previously healthy person. Under treatment with sulfadiazine they developed oliguria, abdominal pain, renal failure and showed multiple radiolucent renal calculi in echography. All patients recovered their previous normal renal function after adequate hydration and alcalinization. A nephrostomy tube had to be placed in one of the patients for ureteral lithiasis in a single functional kidney. None of them needed dialysis or a renal biopsy because of a typical benign course. Treatment with sulfadiazine requires exquisite control of renal function, an increase in water ingestion and possibly the alcalinization of the urine. We communicate a case in a previously healthy person, a fact not found in the recent literature. Probably many more cases are not detected. We think that a prospective study would be useful.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10939760

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  8 in total

1.  Significant reduction of brain cysts caused by Toxoplasma gondii after treatment with spiramycin coadministered with metronidazole in a mouse model of chronic toxoplasmosis.

Authors:  Wai Kit Chew; Ignacio Segarra; Stephen Ambu; Joon Wah Mak
Journal:  Antimicrob Agents Chemother       Date:  2012-01-23       Impact factor: 5.191

Review 2.  Drug-Induced Kidney Stones and Crystalline Nephropathy: Pathophysiology, Prevention and Treatment.

Authors:  Michel Daudon; Vincent Frochot; Dominique Bazin; Paul Jungers
Journal:  Drugs       Date:  2018-02       Impact factor: 9.546

3.  Toxoplasma gondii retinochoroiditis after cardiac transplantation.

Authors:  John Conrath; Annick Mouly-Bandini; Frederic Collart; Bernard Ridings
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-03-22       Impact factor: 3.117

Review 4.  Sulfadiazine-induced nephrolithiasis in children.

Authors:  Charlotte Catalano-Pons; Sophie Bargy; Deborah Schlecht; Marie-Dominique Tabone; George Deschênes; Albert Bensman; Tim Ulinski
Journal:  Pediatr Nephrol       Date:  2004-06-17       Impact factor: 3.714

Review 5.  Drug-induced renal calculi: epidemiology, prevention and management.

Authors:  Michel Daudon; Paul Jungers
Journal:  Drugs       Date:  2004       Impact factor: 9.546

6.  Targeting Toxoplasma gondii CPSF3 as a new approach to control toxoplasmosis.

Authors:  Andrés Palencia; Alexandre Bougdour; Marie-Pierre Brenier-Pinchart; Bastien Touquet; Rose-Laurence Bertini; Cristina Sensi; Gabrielle Gay; Julien Vollaire; Véronique Josserand; Eric Easom; Yvonne R Freund; Hervé Pelloux; Philip J Rosenthal; Stephen Cusack; Mohamed-Ali Hakimi
Journal:  EMBO Mol Med       Date:  2017-03       Impact factor: 12.137

7.  Curcumin nanoemulsion as a novel chemical for the treatment of acute and chronic toxoplasmosis in mice.

Authors:  Sanaz Jafarpour Azami; Aref Teimouri; Hossein Keshavarz; Amir Amani; Fariba Esmaeili; Hamid Hasanpour; Samira Elikaee; Hamid Salehiniya; Saeedeh Shojaee
Journal:  Int J Nanomedicine       Date:  2018-11-09

8.  In vitro Evaluation of Mannosylated Paromomycin-Loaded Solid Lipid Nanoparticles on Acute Toxoplasmosis.

Authors:  Mojdeh Khosravi; Hanieh Mohammad Rahimi; Delaram Doroud; Elnaz Sadat Mirsamadi; Hamed Mirjalali; Mohammad Reza Zali
Journal:  Front Cell Infect Microbiol       Date:  2020-02-13       Impact factor: 5.293

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.